Analysts have largely kept their calls and target prices unchanged following Mapletree Commercial Trust’s (MCT) 1QFY2021/2022 ended June results, which were released late last week.

See also: Mapletree Commercial Trust posts 23% higher NPI of $96.9 mil for 1QFY21/22

UOB Kay Hian was the sole analyst with an adjustment in target price, revising it downwards to $2.48 from $2.50 previously while keeping its “buy” call.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook